Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Analiz Rodriguez

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
JAMA Neurology|July 7, 2025
Interstitial Thermal Therapy in Mesial Temporal Lobe EpilepsyPatrick Landazuri, Jennifer J Cheng, Eric Leuthardt, et al.
Scientific Reports|August 28, 2024
Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade gliomaAubrey Ledford, Analiz Rodriguez, Lindsay Lipinski, et al.
Neuro-Oncology|January 31, 2022
Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastomaChristine E Brown, Analiz Rodriguez, Joycelynne Palmer, et al.
Cells|December 24, 2021
A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for GlioblastomaMegan R Reed, A Geoffrey Lyle, Annick De Loose, et al.
Frontiers in Oncology|October 8, 2024
Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyondAnaliz Rodriguez, Manmeet S Ahluwalia, Chetan Bettegowda, et al.
Neurosurgery|April 16, 2021
Re-evaluating Biopsy for Recurrent Glioblastoma: A Position Statement by the Christopher Davidson Forum InvestigatorsEdjah K Nduom, Melanie Hayden Gephart, Milan G Chheda, et al.
Nature Medicine|July 21, 2025
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trialFarshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Nature Medicine|May 15, 2023
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trialFarshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Cell Systems|April 20, 2023
Modeling collective cell behavior in cancer: Perspectives from an interdisciplinary conversationFrederick R Adler, Alexander R A Anderson, Abhinav Bhushan, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
JAMA Neurology|July 7, 2025
Interstitial Thermal Therapy in Mesial Temporal Lobe EpilepsyPatrick Landazuri, Jennifer J Cheng, Eric Leuthardt, et al.
Scientific Reports|August 28, 2024
Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade gliomaAubrey Ledford, Analiz Rodriguez, Lindsay Lipinski, et al.
Neuro-Oncology|January 31, 2022
Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastomaChristine E Brown, Analiz Rodriguez, Joycelynne Palmer, et al.
Cells|December 24, 2021
A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for GlioblastomaMegan R Reed, A Geoffrey Lyle, Annick De Loose, et al.
Frontiers in Oncology|October 8, 2024
Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyondAnaliz Rodriguez, Manmeet S Ahluwalia, Chetan Bettegowda, et al.
Neurosurgery|April 16, 2021
Re-evaluating Biopsy for Recurrent Glioblastoma: A Position Statement by the Christopher Davidson Forum InvestigatorsEdjah K Nduom, Melanie Hayden Gephart, Milan G Chheda, et al.
Nature Medicine|July 21, 2025
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trialFarshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Nature Medicine|May 15, 2023
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trialFarshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Cell Systems|April 20, 2023
Modeling collective cell behavior in cancer: Perspectives from an interdisciplinary conversationFrederick R Adler, Alexander R A Anderson, Abhinav Bhushan, et al.
Pageof 9